| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |